Perfil
Ori Kalid was the founder of Pi Therapeutics Ltd., founded in 2015, and held the title of Chief Executive Officer.
Dr. Kalid is currently Vice President-Research & Development at Protalix Biotherapeutics, Inc. since 2024.
Formerly, Dr. Kalid was Chief Executive Officer at Pi Therapeutics Ltd. Dr. Kalid completed undergraduate, graduate, and doctorate degrees at Tel-Aviv University.
Cargos activos de Ori Kalid
| Empresas | Cargo | Inicio |
|---|---|---|
| PROTALIX BIOTHERAPEUTICS, INC. | Director Técnico/Científico/I+D | 01/06/2024 |
Antiguos cargos conocidos de Ori Kalid.
| Empresas | Cargo | Fin |
|---|---|---|
Pi Therapeutics Ltd.
Pi Therapeutics Ltd. BiotechnologyHealth Technology Develops a proprietary cancer drug | Director Ejecutivo | - |
Pi Therapeutics Ltd.
Pi Therapeutics Ltd. BiotechnologyHealth Technology Develops a proprietary cancer drug | Director Ejecutivo | - |
Formación de Ori Kalid.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 3 |
|---|---|
Tel-Aviv University
Tel-Aviv University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Protalix Biotherapeutics, Inc.
Protalix Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets recombinant therapeutic proteins | Health Technology |
Pi Therapeutics Ltd.
Pi Therapeutics Ltd. BiotechnologyHealth Technology Develops a proprietary cancer drug | Health Technology |
- Bolsa de valores
- Insiders
- Ori Kalid
















